ATE56149T1 - Verfahren zum pasteurisieren von fibronectin. - Google Patents

Verfahren zum pasteurisieren von fibronectin.

Info

Publication number
ATE56149T1
ATE56149T1 AT84104493T AT84104493T ATE56149T1 AT E56149 T1 ATE56149 T1 AT E56149T1 AT 84104493 T AT84104493 T AT 84104493T AT 84104493 T AT84104493 T AT 84104493T AT E56149 T1 ATE56149 T1 AT E56149T1
Authority
AT
Austria
Prior art keywords
fibronectin
pasteurizing
polyol
preserving
physical
Prior art date
Application number
AT84104493T
Other languages
English (en)
Inventor
Ricardo H Landaburu
Godfrey Amphlett
Roy E Branson
Arthur B Shaw
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Application granted granted Critical
Publication of ATE56149T1 publication Critical patent/ATE56149T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Conductive Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Disintegrating Or Milling (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Materials For Medical Uses (AREA)
AT84104493T 1983-04-29 1984-04-19 Verfahren zum pasteurisieren von fibronectin. ATE56149T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48988683A 1983-04-29 1983-04-29
EP84104493A EP0124044B1 (de) 1983-04-29 1984-04-19 Verfahren zum Pasteurisieren von Fibronectin

Publications (1)

Publication Number Publication Date
ATE56149T1 true ATE56149T1 (de) 1990-09-15

Family

ID=23945685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84104493T ATE56149T1 (de) 1983-04-29 1984-04-19 Verfahren zum pasteurisieren von fibronectin.

Country Status (7)

Country Link
EP (1) EP0124044B1 (de)
JP (1) JPS59206313A (de)
AT (1) ATE56149T1 (de)
AU (1) AU568849B2 (de)
CA (1) CA1213827A (de)
DE (1) DE3483114D1 (de)
ZA (1) ZA842983B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
FR2630115B1 (fr) * 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue
JP2524248B2 (ja) * 1990-06-26 1996-08-14 寶酒造株式会社 新規制ガン剤
EP0440509A3 (en) * 1990-02-02 1991-12-18 Common Services Agency Novel cell growth medium components and process for producing same
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AT402892B (de) * 1992-12-16 1997-09-25 Immuno Ag Verfahren zur herstellung eines virussicheren biologischen präparates
JP3133338B2 (ja) * 1992-12-16 2001-02-05 イムノ・アクチエンゲゼルシャフト ウイルス的に安全な生物学的組成物の調製方法
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035204B2 (de) * 1980-03-05 1991-05-22 Miles Inc. Pasteurisierte therapeutisch aktive Proteinzusammensetzungen
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
EP0050061B2 (de) * 1980-10-06 1990-06-20 New York Blood Center, Inc. Verfahren zum Vermindern unerwünschter Wirkungen biologischer und pharmazeutischer Produkte
DE3043857A1 (de) * 1980-11-21 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ii und vii
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
CA1208551A (en) * 1982-12-27 1986-07-29 Ricardo H. Landaburu Solvent treatment of plasma protein products

Also Published As

Publication number Publication date
EP0124044A3 (en) 1985-07-31
AU568849B2 (en) 1988-01-14
EP0124044A2 (de) 1984-11-07
CA1213827A (en) 1986-11-12
DE3483114D1 (de) 1990-10-11
AU2740384A (en) 1984-11-01
ZA842983B (en) 1984-11-28
EP0124044B1 (de) 1990-09-05
JPS59206313A (ja) 1984-11-22

Similar Documents

Publication Publication Date Title
DE3787686D1 (de) Verfahren zum Aufbewahren und Behandeln von Blut.
DE3473407D1 (en) Method of inactivating pathogens
DE69432351D1 (de) Verfahren zum sterilisieren von produkten
DE3579129D1 (de) Zusammensetzung und verfahren zur behandlung von kunststoffen mit alkalipermanganat-loesungen.
ATE73351T1 (de) Verfahren zur sterilisation von plasma oder plasmafraktionen.
ATE30511T1 (de) Verfahren zur desinfektion und reinigung von kontaktlinsen.
DE3485552D1 (de) Einrichtung zum aufnehmen und behandeln von blut.
NZ194034A (en) Process and apparatus for pulping wood,oxygen treatment by in-line mixer with subsequent storage or washing
DE3166201D1 (en) Process for the preparation of blood coagulation factors, and preparation containing factors ii and vii
FI875019L (fi) Kankaiden käsittelyssä käytettävä tuote ja menetelmä kankaiden käsittelemiseksi
DE3483114D1 (de) Verfahren zum pasteurisieren von fibronectin.
FI830050A7 (fi) Menetelmä puun ja puuainesten käsittelemiseksi vesipitoisilla käsittelyaineilla.
ATE24823T1 (de) Pasteurisierung von eiern.
PT77464A (de) Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipittat
DE3750714D1 (de) Verfahren zur Behandlung von Kohlenstoffasern mit Urethanen.
DE68923481D1 (de) Verfahren zum Behandeln von Sojabohnen.
PT79318A (de) Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii,vii,ix e x
DE3768397D1 (de) Verfahren und vorrichtung zum transport von glasscheiben waehrend des erhitzens und kuehlens.
PT79117A (de) Verfahren zur pasteurisierung von humanplasma
EP0120835A3 (en) Process for the inactivation of incompatibility inducing substances
DE58904294D1 (de) Beheizte foerdervorrichtung und verfahren zum desinfizieren von kontaminiertem, zerkleinertem krankenhausmuell.
DE69119707D1 (de) Einstufiges verfahren zur konservierung von kontaktlinsen
DE3781279D1 (de) Verfahren zur behandlung von blut.
JPS57115175A (en) Method and apparatus for treating bacteria cultivating dish
AT330108B (de) Verfahren zur warmebehandlung, insbesondere zur sterilisation oder desinfektion, von wasserhaltigen schlammen und vorrichtung zur durchfuhrung des verfahrens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee